Back

Major adverse cardiovascular events (MACE) are reduced in testosterone-treated vs. untreated hypogonadal men: real-life evidence from a controlled registry study

29 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 7 - Prevention general Primary cardiovascular prevention: interventions and outcomes ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Farid Saad

Bayer AG, Berlin (Germany)

27 More presentations in this session

Presentation thumbnail
Professor J. Argacha (Brussels, BE)
Abstract Slides
Presentation thumbnail
Doctor N. Arnold (Hamburg, DE)
Abstract
Presentation thumbnail
Doctor J. Wu (Toufen, TW)
Abstract Slides
Presentation thumbnail
Professor S. Boldueva (Saint Petersburg, RU)
Abstract
Presentation thumbnail
Doctor P. Conley (South San Francisco, US)
Abstract

Access the full session

Session thumbnail
Poster session 7 - Prevention general

The Event

Event poster

ESC Congress 2017

29 August 2017 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources